Skip to content

Latest Imaging SPECT System Evaluation Phase 1

Latest Imaging SPECT System Evaluation Phase 1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04704349
Acronym
LISSE1
Enrollment
68
Registered
2021-01-11
Start date
2020-10-05
Completion date
2021-01-27
Last updated
2021-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Heart Diseases, Kidney Diseases, Neoplasms, Parathyroid Diseases, Parkinsonian Disorders, Pulmonary Embolism, Rheumatic Disease, Thyroid Diseases

Keywords

Gamma camera, whole body scan, scintigraphy

Brief summary

Monocentric study for the evaluation of a whole body CZT scintigraphy system.

Detailed description

Monocentric evaluation of performances and clinical interest of a whole body scintigraphic acquisition system with CZT digital detectors. Comparison of image quality and resolution of the new system compared to a reference one, on phantoms and during the acquisition of a wide variety of examinations.

Interventions

RADIATIONScintigraphy

The scintigraphy of the patients will be carried out on 2 distinct devices and the images obtained will be compared.

Sponsors

Centre Hospitalier Régional d'Orléans
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

All patients will undergo scintigraphy on 2 distinct devices and the images obtained will be compared.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients referred to our Nuclear Medicine department for bone, cardiac, pulmonary, thyroid, parathyroid, renal or cerebral perfusion scintigraphy or to DaTSCAN.

Exclusion criteria

* Under 18 years old patients. * Pregnant women or at risk of pregnancy. * Patients under guardianship * Painful patient (EVA\>4) * Patients in whom a standard examination is not feasible (agitation).

Design outcomes

Primary

MeasureTime frameDescription
Rate of images with a score greater than or equal to 4Day 0Rate of images obtaining a score greater than or equal to 4 in visual image quality analysis on a 5-point LIKERT scale.

Secondary

MeasureTime frameDescription
collimator performanceDay 0Physical measurements of collimator performance on test object.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026